FDA Approves Talicia (omeprazole magnesium, amoxicillin and rifabutin) for the Treatment of H. pylori Infection in Adults
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 04, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the“Company”), a specialty biopharmaceutical company primarily focused... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 4, 2019 Category: Drugs & Pharmacology Source Type: news
FDA OKs First Rifabutin-Based H Pylori Therapy Talicia FDA OKs First Rifabutin-Based H Pylori Therapy Talicia
Talicia combines omeprazole, amoxicillin, and rifabutin and is designed to address growing bacterial resistance to standard clarithromycin-based H pylori therapy.FDA Approvals (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 4, 2019 Category: Intensive Care Tags: Infectious Diseases News Alert Source Type: news
FDA says Pepcid and Prilosec do NOT contain carcinogen in Zantac
The Food and Drug Administration on Wednesday told Americans that Prilosec, Pepcid and other alternatives are free of NDMA found in Zantac - but they have other risks. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2019 Category: Consumer Health News Source Type: news
AstraZeneca divests rights for Losec to Cheplapharm
AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arzneimittel GmbH (Cheplapharm). The divestment includes medicines containing omeprazole marketed by AstraZeneca or its collaborators under the Acimax, Antra, Mepral, Mopral, Omepral and Zoltum medicine names. (Source: World Pharma News)
Source: World Pharma News - October 1, 2019 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
CVS Halts Sale of Heartburn Treatment Zantac as FDA Warns of Contaminants
CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators.
It’s the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.
In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications.
What’s the issue?
In September, the FDA said it detected low levels of a probabl...
Source: TIME: Health - September 30, 2019 Category: Consumer Health News Authors: LINDA A. JOHNSON / AP Tags: Uncategorized medicine onetime Source Type: news
36% of proton pump inhibitor prescriptions for older adults may be unneeded
FINDINGSOne in eight older adults was prescribed proton pump inhibitor drugs, which are used to treat gastric ulcers or to prevent gastrointestinal bleeding in those taking blood thinners. About 36 percent of those prescriptions were potentially unnecessary, a study found, primarily because people took them far longer than the often-recommended eight weeks.BACKGROUNDOlder Americans frequently receive low-value care, which is care that has no net benefit to the individual and has the potential to harm them. Low-value care contributes significantly to higher health costs. Most people are unaware of the potential toxicity o...
Source: UCLA Newsroom: Health Sciences - September 5, 2019 Category: Universities & Medical Training Source Type: news
Spanish Parents Sue After Acid Reflux Medication Mix Up Leaves Babies With ‘Abnormal’ Body Hair Growth
(MADRID) — Parents of babies and toddlers in Spain who have developed abnormal body hair plan to sue a pharmaceutical company that put a treatment for hair loss into packages meant for addressing acid reflux and other conditions.
Spanish health authorities have blamed the Minoxidil mix-up on Farma-Química Sur. They say the well-known topical treatment was put in packaging that was supposed to contain a syrup with omeprazole, which is used for stomach problems.
Spain’s Health Ministry has said at least 20 children from the age of a few weeks to two years have been affected.
The mother of a 10-month old bo...
Source: TIME: Health - August 31, 2019 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized onetime Spain Source Type: news
Medical News Today: What to know about omeprazole
This article looks at its uses, dosage, and side effects, as well as what to know before taking the medication. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 24, 2019 Category: Consumer Health News Tags: Acid Reflux / GERD Source Type: news
Low-Income Countries Pay Over 20 Times More for Generic Drugs
By Caley PigliucciUNITED NATIONS, Jun 21 2019 (IPS) A recently-released report by the Washington-based Center for Global Development (CGD) shows that generic drugs, like omeprazole (used to treat heartburn), can cost 20-30 times more in low and middle-income countries than in high-income countries.
Rachel Silverman, a researcher with CGD who worked on the report, told IPS that “There is a lack of competition at the country level, even for basic, off-patent generic medicines. One firm can sometimes control 85% or more of the market share for specific drugs or therapy classes in some countries.”
The report also...
Source: IPS Inter Press Service - Health - June 21, 2019 Category: International Medicine & Public Health Authors: Caley Pigliucci Tags: Aid Development & Aid Economy & Trade Global Headlines Health Population TerraViva United Nations Source Type: news
Digestive enzymes vs. omeprazole (Prilosec)
Title: Digestive enzymes vs. omeprazole (Prilosec)Category: MedicationsCreated: 6/19/2019 12:00:00 AMLast Editorial Review: 6/19/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 19, 2019 Category: Drugs & Pharmacology Source Type: news
Heartburn Drugs Can Lead to Fatal Heart or Kidney Disease
Proton pump inhibitors like Prevacid and Prilosec should be taken at low doses and for the shortest time possible. (Source: NYT Health)
Source: NYT Health - June 11, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Heartburn Ulcers Kidneys Source Type: news
Carafate (sucralfate) vs. Prilosec (omeprazole)
Title: Carafate (sucralfate) vs. Prilosec (omeprazole)Category: MedicationsCreated: 6/7/2019 12:00:00 AMLast Editorial Review: 6/7/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 7, 2019 Category: Drugs & Pharmacology Source Type: news
Overuse of heartburn drugs linked to heart, kidney disease, cancer
Researchers have linked popular drugs like Prevacid, Prilosec, Nexium and other proton pump inhibitors to a higher risk of death by cardiovascular and chronic kidney disease, as well as upper gastrointestinal cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 30, 2019 Category: Consumer Health News Source Type: news
Common acid reflux medications linked to increased kidney disease risk
(University of California - San Diego) Mining a large database of adverse reactions to medications, UC San Diego researchers found that people who took proton pump inhibitors (e.g., Prilosec, Nexium) for heartburn and acid reflux were more likely to experience kidney disease than people who took other forms of antacid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2019 Category: International Medicine & Public Health Source Type: news
